Cheese

Flower reigns supreme, whether buying it as buds and flowers or having those buds and flowers pre-rolled into joints for you, smoking cannabis is still the king according to a new industry study! With customer tastes changing toward convenience and ready-to-use products, pre-rolled joints have transformed from a niche product to a retail mainstay, quickly becoming one of the cannabis industry's fastest-growing segments.

According to the findings, the individuals who historically consumed cannabis occasionally had the best results. They also added that frequent marijuana consumption was not linked to a decrease in cognitive performance during the trial.

The potential acquisition of Syqe Medical by Phillip Morris represents a significant strategic move for the tobacco giant, signaling its entry into the flourishing marijuana industry. With an initial investment of $130 million to support Syqe's FDA approval process, followed by a possible $650 million acquisition, this deal can potentially make Syqe one of the largest cannabis companies globally. Moreover, Syqe's innovative inhaler, utilizing raw cannabis inflorescence, could secure FDA approval, positioning the company as a trailblazer in the medical cannabis sector.